AFMD
Affimed NV
NASDAQ: AFMD · HEALTHCARE · BIOTECHNOLOGY
$0.18
+0.00% today
Updated 2026-04-29
Market cap
$2.98M
P/E ratio
—
P/S ratio
0.53x
EPS (TTM)
$-5.09
Dividend yield
—
52W range
$0 – $1
Volume
23.5M
Affimed NV (AFMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17M | $5.09M | $3.38M | $7.56M | $6.31M | $2.01M | $23.73M | $21.39M | $28.36M | $40.37M | $41.35M | $8.28M |
| Revenue growth (YoY) | — | +333.7% | -33.5% | +123.6% | -16.5% | -68.2% | +1080.8% | -9.9% | +32.6% | +42.3% | +2.4% | -80.0% |
| Cost of revenue | $550000.00 | $710000.00 | $840000.00 | $902000.00 | $1.03M | $994000.00 | $1.14M | $1.55M | — | — | — | — |
| Gross profit | $1.17M | $5.09M | $3.38M | $7.56M | $6.31M | $2.01M | $23.73M | $21.39M | $28.36M | $40.37M | $41.35M | $8.28M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $8.73M | $14.35M | $9.60M | $22.01M | $30.18M | $21.49M | $35.15M | $43.79M | $49.99M | $81.49M | $98.81M | $94.96M |
| SG&A | $3.05M | $7.05M | $2.35M | $7.55M | $8.32M | $7.99M | $9.64M | $10.27M | $13.71M | $24.22M | $32.08M | $24.68M |
| Operating income | $-10.40M | $-15.70M | $-8.18M | $-21.34M | $-32.04M | $-27.26M | $-19.54M | $-32.38M | $-34.72M | $-64.03M | $-88.12M | $-106.66M |
| Operating margin | -886.4% | -308.7% | -241.8% | -282.2% | -507.5% | -1356.2% | -82.3% | -151.4% | -122.4% | -158.6% | -213.1% | -1289.0% |
| EBITDA | $-9.99M | $-15.27M | $-8.12M | $-19.20M | $-31.10M | $-27.26M | $-18.88M | $-30.97M | $-34.23M | $-64.01M | $-81.47M | $-102.38M |
| EBITDA margin | -851.5% | -300.1% | -240.0% | -253.9% | -492.6% | -1356.2% | -79.5% | -144.8% | -120.7% | -158.6% | -197.0% | -1237.2% |
| EBIT | $-10.40M | $-15.69M | $-8.56M | $-19.54M | $-31.49M | $-27.59M | $-19.29M | $-31.88M | $-35.27M | $-65.39M | $-84.32M | $-104.13M |
| Interest expense | $3.93M | $10.41M | $4.28M | $703000.00 | $803000.00 | $690000.00 | $847000.00 | $483000.00 | $95000.00 | $712000.00 | $1.63M | $1.81M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-14.31M | $-26.10M | $-259000.00 | $-20.24M | $-32.22M | $-30.22M | $-19.48M | $-32.37M | $-41.37M | $-57.52M | $-86.00M | $-105.94M |
| Net income growth (YoY) | — | -82.3% | +99.0% | -7714.3% | -59.2% | +6.2% | +35.6% | -66.2% | -27.8% | -39.1% | -49.5% | -23.2% |
| Profit margin | -1220.3% | -513.1% | -7.7% | -267.6% | -510.2% | -1503.6% | -82.1% | -151.3% | -145.9% | -142.5% | -208.0% | -1280.2% |